Prospects for leveraging the microbiota as medicine for hypertension

DJ Durgan, J Zubcevic, M Vijay-Kumar, T Yang… - …, 2024 - Am Heart Assoc
Prospects for Leveraging the Microbiota as Medicine for Hypertension | Hypertension Science
Volunteer Warning signs SearchSearch Advanced Search Donate Hypertension logo Hello …

Clinical trials targeting the gut-microbiome to effect ocular health: a systematic review

MW Russell, JC Muste, BL Kuo, AK Wu, RP Singh - Eye, 2023 - nature.com
Clinical trials targeting the gut microbiome to mitigate ocular disease are now on the
horizon. A review of clinical data thus far is essential to determine future directions in this …

Dysregulation of amino acid, lipid, and acylpyruvate metabolism in idiopathic intracranial hypertension: A non-targeted case control and longitudinal metabolomic …

Z Alimajstorovic, SP Mollan, O Grech… - Journal of Proteome …, 2022 - ACS Publications
Background: Idiopathic intracranial hypertension (IIH) is characterized by increased
intracranial pressure occurring predominantly in women with obesity. The pathogenesis is …

[PDF][PDF] Dysregulation of amino acid, lipid and acylpyruvate metabolism in idiopathic intracranial hypertension

Z Alimajstorovic, S Mollan, O Grech, J Mitchell… - research.birmingham.ac.uk
Background: Idiopathic intracranial hypertension (IIH) is characterized by increased
intracranial pressure occurring predominantly in women with obesity. The pathogenesis is …